title: Antidepressant use and new-onset diabetes: a systematic review and meta-analysis.
abstract: Antidepressant use has been linked to new-onset diabetes. However, the existing literature on this relationship has yielded inconsistent findings. The primary objective of this study was to systematically synthesize the literature on the relationship between antidepressant use and new-onset diabetes using meta-analysis. A systematic literature search was conducted to identify relevant studies in seven electronic databases. Two independent reviewers identified the final list of studies to be included in the meta-analysis using a priori selection criteria. Results for the primary outcome of interest, that is, odds and hazards of developing new-onset diabetes, were pooled using a random-effects model. Egger's regression test and the Trim and Fill method were utilized to detect the presence of any potential publication bias. Sensitivity analysis was conducted using the leave-one-out method as well as individual categories of antidepressant drugs. Eight studies met the inclusion criteria. Random effects models revealed that adults with any use of antidepressants were more likely to develop new-onset diabetes compared with those without any use of antidepressants [odd ratios = 1.50, 95% confidence interval (CI), 1.08-2.10; hazards ratio = 1.19, 95% CI, 1.08-1.32]. Sensitivity analyses revealed fair robustness; selective serotonin reuptake inhibitors and tricyclic antidepressants were more likely to be associated with the development of new-onset diabetes. Results from the Egger's regression test and Trim and Fill method revealed no evidence of publication bias. Among adults, antidepressant use was associated with higher chances of new-onset diabetes. However, because a cause-and-effect relationship cannot be established by observational studies, future randomized controlled studies are needed to confirm this association.
authors: Department of Pharmaceutical Systems and Policy, School of Pharmacy, West Virginia University, Morgantown, WV, USA. sbhattacharjee@hsc.wvu.edu
authors: Sandipan
authors: S
authors: Bhattacharjee
authors: Rituparna
authors: R
authors: Bhattacharya
authors: George A
authors: GA
authors: Kelley
authors: Usha
authors: U
authors: Sambamoorthi
mesh_terms: D000328:Adult; D006801:Humans; D000928:Antidepressive Agents / Q000009:adverse effects; D003924:Diabetes Mellitus, Type 2 / Q000139:chemically induced
chemical_list: D000928:Antidepressive Agents
references: J Clin Psychiatry. 2011 May;72(5):e18
references: 21658343
references: Health Aff (Millwood). 2011 Aug;30(8):1434-42
references: 21821561
references: Psychother Psychosom. 2010;79(5):267-79
references: 20616621
references: Eur J Pharmacol. 1990 Oct 23;187(3):435-43
references: 2127400
references: Am J Psychiatry. 2009 May;166(5):591-8
references: 19339356
references: BMJ. 1997 Sep 13;315(7109):629-34
references: 9310563
references: Diabetes Care. 1994 Sep;17(9):961-9
references: 7988316
references: Nature. 2006 Dec 14;444(7121):840-6
references: 17167471
references: Diabetologia. 2012 Jan;55(1):63-72
references: 21811871
references: Int J Geriatr Psychiatry. 2010 Jul;25(7):688-96
references: 19806604
references: BMJ. 2003 Sep 6;327(7414):557-60
references: 12958120
references: Am J Psychiatry. 2007 Feb;164(2):201-4
references: 17267779
references: Int Clin Psychopharmacol. 2011 May;26(3):159-68
references: 21471774
references: Diabetologia. 2006 May;49(5):837-45
references: 16520921
references: Br J Clin Pharmacol. 1994 Feb;37(2):181-6
references: 8186063
references: Acta Psychiatr Scand. 2005 Dec;112(6):425-33
references: 16279871
references: Diabetes Care. 1996 Oct;19(10):1097-102
references: 8886555
references: J Pharmacol Exp Ther. 1992 Mar;260(3):1008-16
references: 1545373
references: Diabetes Care. 1999 Jul;22(7):1071-6
references: 10388970
references: Diabetes Res Clin Pract. 2010 Aug;89(2):189-95
references: 20363043
references: Biometrics. 2000 Jun;56(2):455-63
references: 10877304
references: Psychiatr Serv. 2008 Dec;59(12):1391-8
references: 19033165
references: Int Clin Psychopharmacol. 2007 Nov;22(6):382-6
references: 17917558
references: Diabetes Care. 2008 Jan;31 Suppl 1:S12-54
references: 18165335
references: Biol Pharm Bull. 1999 Nov;22(11):1240-1
references: 10598036
references: Mol Cell Neurosci. 2007 Nov;36(3):305-12
references: 17728140
references: Eur J Pharmacol. 1999 Oct 15;382(3):211-5
references: 10556672
references: BMC Med. 2011 Jun 15;9:74
references: 21676220
references: Diabetes Care. 2008 Mar;31(3):420-6
references: 18071002
references: J Psychiatr Res. 2003 May-Jun;37(3):193-220
references: 12650740
references: Eur J Clin Pharmacol. 2012 Sep;68(9):1295-302
references: 22120432
references: Diabetes Care. 2011 Nov;34(11):2390-2
references: 21911776
references: World Psychiatry. 2012 Feb;11(1):3-10
references: 22294996
references: Am J Psychiatry. 2009 Sep;166(9):1065-6; author reply 1066
references: 19723798
references: Neuropeptides. 2004 Apr-Jun;38(2-3):98-105
references: 15223272
references: Ann Intern Med. 1995 Apr 1;122(7):481-6
references: 7872581
references: Ann Intern Med. 2004 Apr 20;140(8):650-8
references: 15096337
references: Bull World Health Organ. 2007 Nov;85(11):867-72
references: 18038077
references: Biol Psychiatry. 2011 Nov 15;70(10):978-84
references: 21872216
references: Diabetes Care. 2010 Dec;33(12):2611-6
references: 20823343